Table 1 Characteristic of patients in Ningbo Medical Center Li Huili Hospital and The First Afflicted Hospital of Ningbo University.

From: Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer

Characteristic

 

LHL hospital (n = 42)

The first hospital (n = 40)

p-value

Age, n (%)

 < 60

14 (33.3)

15 (37.5)

0.89

 ≥ 60

28 (69.7)

25 (62.5)

Gender, n (%)

Male

22 (52.4)

15 (37.5)

0.18

Female

20 (47.6)

25 (62.5)

T-Stage, n (%)

T1-2

2 (4.8)

1 (2.5)

0.82

T3

14 (33.3)

14 (35.0)

T4

26 (61.9)

30 (75.0)

N-Stage, n (%)

N1

19 (45.2)

10 (25.0)

0.55

N2

23 (54.8)

26 (65.0)

M-Stage, n (%)

M0

29 (69.0)

22 (68.8)

0.11

M1

13 (31.0)

10 (31.2)

CEA level, n (%)

Normal

17 (40.5)

22 (55.0)

0.19

Abnormal

25 (59.5)

18 (45.0)

Tumor location, n (%)

Right

15 (35.7)

11 (25.5)

0.15

Left

27 (64.3)

29 (74.5)

BRAF gene status

Wild

37 (88.1)

35 (87.5)

0.89

Mutation

5 (11.9)

5 (22.5)

RAS gene status

Wild

28 (66.7)

22 (55.0)

0.28

Mutation

14 (33.3)

18 (45.0)

  1. CEA Carcinoembryonic antigen.
  2. LHL hospital: Ningbo Medical Center Li Huili Hospital.
  3. The first hospital: The First Afflicted Hospital of Ningbo University.